Curated GI articles Apr 10th, 2021: FDA approves first AI Device (GI Genius) to detect colon lesions
Curated GI articles Apr 10th, 2021:
FDA approves first AI Device (GI Genius) to detect colon lesions
Dr. Scott Ketover: “The future of GI remains bright. Because if it goes in your mouth, it’s in our domain” (Interview) (NextServices)
Dr. Scott Ketover is the President and CEO of MNGI Digestive Health (previously Minnesota Gastroenterology). Find out about MNGI’s growth strategy and more in this insightful interview.
About 1 in 5 Clinicians Considers Quitting Due to Pandemic: Survey (Medscape)
The COVID-19 pandemic continues to take its toll on the well-being and work satisfaction of healthcare providers, a new survey of more than 5,000 clinicians at an academic medical center illustrates.
Linked color imaging may improve adenoma detection in endoscopy (Healio)
Endoscopy with linked color imaging may help improve adenoma detection, particularly among endoscopists who normally have lower adenoma detection rates, according to study results.
FDA Approves First AI Device to Detect Colon Lesions (Medscape)
The GI Genius (Cosmo Artificial Intelligence) identifies areas of the colon where a colorectal polyp or tumor might be located. Clinicians then follow up with a closer examination and possible treatment.
GI partnerships, acquisitions and openings: 9 industry updates (Becker’s GI & Endoscopy)
GI companies have been busy in the past month, from ASC acquisitions to partnerships. Here are nine updates from GI companies and physicians.
ACG Clinical Guidelines: Colorectal Cancer Screening 2021 (AJG)
The “ideal” screening test should be noninvasive, have high sensitivity and specificity, be safe, readily available, convenient, and inexpensive.
7 recent reports on COVID-19 in GI (Healio)
These reports include new research on the impact of COVID-19 in GI bleeding, GI neoplasia detection, transmission during endoscopy and its effect on fecal microbiota transmission.
Walgreens Not Following U.S. Guidance on Pfizer Vaccine Spacing (The New York Times)
After complaints from customers and the C.D.C., the pharmacy chain will start scheduling doses three weeks apart.
Will the pandemic spark more ASC sales? 4 observations (Becker’s ASC Review)
Independent surgery centers experienced revenue loss last year when elective surgeries were limited due to COVID-19, but many ramped cases back up and aim to stay independent if possible.
Doctors Accuse UnitedHealthcare of Stifling Competition (The New York Times)
A multistate group of anesthesiologists filed cases in Texas and Colorado, accusing the insurance giant of squeezing them like a “boa constrictor.”
NHS trials edible capsule cameras to detect colon cancer (Mobihealthnews)
The Pillcam Colon 2 technology, from US medical device firm Medtronic, takes images as it passes through the bowel which are transmitted to a recording device worn by the patient at their waist.
OptumCare scaled up its home colon cancer screenings due to COVID-19. Here’s how (Fierce Healthcare)
100,000 tests sent to patients’ homes last year under the pandemic said Daniel Frank, M.D., chief medical officer at OptumCare in an interview
GI leadership updates in Q1 (Becker’s GI & Endoscopy)
At least five gastroenterologists or GI innovators were appointed to leadership positions in the first quarter of 2021. Here are five GI leaders who have been named to leadership positions in the first quarter.
Verizon latest tech giant to elbow into telehealth space with provider platform (Healthcare Drive)
Verizon is joining the crowded virtual care market with the launch of its new telemedicine platform for providers, Verizon BlueJeans, on Monday, banking on continued demand for virtual care post-COVID-19.
Opinion: To stem the pandemic, the U.S. needs a national Covid-19 genomic sequencing effort (STAT)
More than a year into the pandemic, the United States is at yet another critical inflection point. The number of Covid-19 cases remains high and is on the rise in more than half of states.
At-Home Colon Cancer Tests: What Do Doctors Think? (The Healthy)
The pandemic has accelerated the interest in at-home tests and not just from patients. Some health care providers, like Kaiser Permanente, are mailing colon cancer testing kits to members.
CRH Medical acquires remaining interest in GI anesthesia practice (Becker’s GI & Endoscopy)
CRH Medical acquired the remaining 25 percent interest in Gainesville, Ga.-based Lake Lanier Anesthesia Associates, which CRH obtained 75 percent of in June 2020.
Esophageal Cancer: An Updated Review (Medscape)
With the distinct subtypes of adenocarcinoma and squamous cell carcinoma comes specific risk factors, and as a result, people of certain regions of the world can be more prone to a subtype.
IBD Patients Should Be Screened for Anxiety, Depression (Medscape)
Up to one-third of patients with inflammatory bowel disease (IBD) experience anxiety and one-quarter have symptoms of depression, a systematic review and meta-analysis reveals.
Prior authorizations lead to serious patient adverse events, 30% of physicians say (Becker’s Hospital CFO Report)
Thirty percent of physicians said that prior authorizations have led to a serious adverse event for a patient in their care, according to research released April 7 by the American Medical Association.